Abstract
Malignant glioma has a dismal prognosis. It was previously shown that glioma cells are efficiently killed when they express a gene coding for a hyperfusogenic mutant of the gibbon ape leukemia virus envelope glycoprotein (GALV.fus). However, production of viral vectors expressing GALV.fus has proven problematic because the transgene is toxic to vector-producing cells of human origin. We reasoned that Sindbis-virus-based vectors might be ideal for GALV.fus gene transfer because high-titer stocks can easily be generated in hamster cells and Sindbis virus efficiently infects human tumor cells through the high-affinity 67 kDa laminin receptor. In addition, Sindbis virus nonstructural proteins are potent inducers of apoptosis, and Sindbis vector RNAs expressing fusogenic viral proteins have been shown to spread from cell-to-cell in membrane-formed infectious particles. Sindbis virus replicon-containing particles were generated by co-transfecting vector and helper RNAs into baby hamster kidney (BHK-21) cells. Packaged beta-galactosidase and GALV.fus expressing Sindbis vectors were used to infect glioma cell lines, which were then compared for syncytial cytopathic effect, cell killing, and release of infectious virus-like particles co...Continue Reading
References
Nov 1, 1992·Neurologia Medico-chirurgica·M MizunoK Sugita
Aug 1, 1992·Journal of Virology·K S WangJ H Strauss
Nov 1, 1991·Journal of Virology·C A Wilson, M V Eiden
Nov 4, 1994·Cell·M M RollsJ K Rose
Nov 1, 1993·Journal of Virology·P J BredenbeekS Schlesinger
Feb 25, 1993·Nature·B LevineJ M Hardwick
Aug 1, 1996·The Journal of Pathology·X SanjuánE Campo
Aug 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F A van den BrûleG Taraboletti
Apr 10, 1996·Human Gene Therapy·Y DongH A Fine
Sep 1, 1997·Journal of Virology·I LebedevaJ Silver
Jan 1, 1997·Annual Review of Microbiology·D E Griffin, J M Hardwick
Nov 26, 1997·The Journal of Pathology·G PelosiG Zamboni
Jan 7, 1998·Journal of Neurosurgery·F G DavisS Brem
Jan 28, 1998·Journal of Virology·T CathomenR Cattaneo
Mar 5, 1999·Breast Cancer Research and Treatment·S MénardM I Colnaghi
Jan 11, 2000·Journal of Virology·S BalachandranG N Barber
Apr 25, 2000·Human Gene Therapy·A K FieldingS J Russell
Jun 23, 2000·Journal of Virology·J T JanD E Griffin
May 8, 2001·Human Gene Therapy·E GalanisS J Russell
Apr 26, 2002·Gene Therapy·S MoriuchiJ C Glorioso
Apr 15, 2003·Human Gene Therapy·Anthony M BradeHenry J Klamut
Dec 3, 2003·Nature Biotechnology·Jen-Chieh TsengDaniel Meruelo
Citations
Nov 13, 2008·Expert Reviews in Molecular Medicine·Gregory J AtkinsBrian J Sheahan
Nov 7, 2009·Cancer Gene Therapy·E-H LinJ-L Coll
Oct 19, 2005·Gene Therapy·E PiverJ-C Pagès
Nov 22, 2005·Oncogene·J Michael MathisDavid T Curiel
Mar 30, 2005·Journal of Virology·Richard W Hardy, Charles M Rice
Nov 22, 2011·Retrovirology·Eleanor R GrayJonathan P Stoye
Oct 30, 2007·Virology Journal·Brian J GeissKen E Olson
Feb 27, 2014·Human Gene Therapy Methods·Gray KueberuwaLeonard W Seymour
Feb 13, 2014·Cell Biochemistry and Biophysics·Bing ZhuYue-quan Jiang
Feb 9, 2011·Cytotherapy·Dominique CathelinBernard Bonnotte
Aug 10, 2010·Virus Research·Jose I QuetglasCristian Smerdou
Mar 27, 2007·Cancer Letters·Markus J V Vähä-KoskelaAri E Hinkkanen
Feb 27, 2007·Neuroscience·J TrojanD D Anthony
May 4, 2010·Journal of Internal Medicine·V Kaminskyy, B Zhivotovsky
Sep 2, 2015·Nature Reviews. Drug Discovery·Howard L KaufmanAndrew Zloza
May 30, 2013·International Journal of Molecular Medicine·Anna HyvärinenRiikka Pellinen
Mar 5, 2019·The Journal of Clinical Investigation·Jordi Martinez-QuintanillaKhalid Shah
Oct 18, 2020·International Journal of Molecular Sciences·Sergio Rius-RocabertEstanislao Nistal-Villan
Dec 3, 2020·Human Gene Therapy·Jing Cai, Guangmei Yan
Mar 31, 2021·Neurosurgery Clinics of North America·Dagoberto Estevez-OrdonezJames M Markert
May 1, 2021·Viruses·Lin DingJohn I Glass